TippingPoint Biosciences
Biotech drugging epigenetic protein interfaces, starting with pediatric brain cancer.
Team
- Laura Hsieh, Founder & CEO
- Geeta Narlikar, Co-founder & Chair of SAB
- Savi Ramurthy, CTO & Head of Medicinal Chemistry
+1 more people. Sign up free to see them.
Verified Telegram, email and LinkedIn for this team, where NAUT has them on file, unlock on any paid plan. Start a 7-day trial
Funding rounds
- Seed · $4.5M · 31 Mar 2026, backed by SOSV